Literature DB >> 35084513

Turkish day-to-day impact of vaginal aging questionnaire: reliability, validity and relationship with pelvic floor distress.

Burcu Sert1, Serap Özgül2.   

Abstract

INTRODUCTION AND HYPOTHESIS: We aimed to translate the Day-to-Day Impact of Vaginal Aging (DIVA) Questionnaire into Turkish, adapt it culturally, and investigate its reliability and validity. Another aim of the study was to examine the relationship between the impacts of vaginal symptoms and pelvic floor symptoms on quality of life (QoL). We hypothesized primarily that the the Turkish DIVA had good internal consistency, test-retest reliability and construct and criterion validity. Our secondary hypothesis was that the effects of vaginal symptoms and pelvic floor symptoms on QoL would be positively related.
METHODS: A total of 218 postmenopausal women were included. In the reliability analyses, Cronbach α coefficients, item-total correlation coefficients and intraclass correlation coefficients (ICCs) were used. Construct validity was investigated with explanatory and confirmatory factor analyses. Criterion validity and the relationship between the effects of vaginal symptoms and pelvic floor symptoms were examined by Pearson correlation analysis.
RESULTS: While the Cronbach's alpha coefficients ranged between 0.87 and 0.96, the item-total score correlation coefficients were 0.60-0.91. ICCs ranged from 0.90 to 0.99. It was found with confirmatory factor analysis that the model fit the data. Moderate-strong correlations (r = 0.47-0.73) were observed between DIVA scores and the scores of other scales (p < 0.001).
CONCLUSIONS: The Turkish DIVA is a reliable and valid tool that comprehensively evaluates the impact of vaginal symptoms on women's QoL. The positive relationship between the impacts of vaginal and pelvic floor symptoms on functionality and well-being of women suggests a holistic view in pelvic health care.
© 2022. The International Urogynecological Association.

Entities:  

Keywords:  Menopause; Patient-reported outcome measures; Pelvic floor; Quality of life; Vaginal symptom

Mesh:

Year:  2022        PMID: 35084513     DOI: 10.1007/s00192-022-05085-w

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   1.932


  23 in total

1.  Vaginal Health: Insights, Views & Attitudes (VIVA) - results from an international survey.

Authors:  R E Nappi; M Kokot-Kierepa
Journal:  Climacteric       Date:  2011-12-14       Impact factor: 3.005

2.  Refinement of the German Day-to-Day Impact of Vaginal Aging questionnaire in perimenopausal and postmenopausal women using item response theory and classical test theory.

Authors:  Michaela Gabes; Petra Stute; Christian J Apfelbacher
Journal:  Menopause       Date:  2020-12-21       Impact factor: 2.953

Review 3.  The NICE Guideline - Menopause: diagnosis and management.

Authors:  M A Lumsden
Journal:  Climacteric       Date:  2016-08-24       Impact factor: 3.005

Review 4.  Symptoms of menopause - global prevalence, physiology and implications.

Authors:  Patrizia Monteleone; Giulia Mascagni; Andrea Giannini; Andrea R Genazzani; Tommaso Simoncini
Journal:  Nat Rev Endocrinol       Date:  2018-02-02       Impact factor: 43.330

5.  Convergent-Divergent Validity and Correlates of the Day-to-Day Impact of Vaginal Aging Domain Scales in the MsFLASH Vaginal Health Trial.

Authors:  Mary M Hunter; Katherine A Guthrie; Joseph C Larson; Susan D Reed; Caroline M Mitchell; Susan J Diem; Andrea Z LaCroix; Alison J Huang
Journal:  J Sex Med       Date:  2019-12-04       Impact factor: 3.802

6.  Measurement properties of patient-reported outcome measures (PROMs) for women with genitourinary syndrome of menopause: a systematic review.

Authors:  Michaela Gabes; Helge Knüttel; Petra Stute; Christian J Apfelbacher
Journal:  Menopause       Date:  2019-11       Impact factor: 2.953

7.  Development and psychometric evaluation of the ICIQ Vaginal Symptoms Questionnaire: the ICIQ-VS.

Authors:  N Price; S R Jackson; K Avery; S T Brookes; P Abrams
Journal:  BJOG       Date:  2006-06       Impact factor: 6.531

8.  The European Vulvovaginal Epidemiological Survey (EVES): prevalence, symptoms and impact of vulvovaginal atrophy of menopause.

Authors:  S Palacios; R E Nappi; N Bruyniks; M Particco; N Panay
Journal:  Climacteric       Date:  2018-03-19       Impact factor: 3.005

9.  The Vulvovaginal Symptoms Questionnaire: a questionnaire for measuring vulvovaginal symptoms in postmenopausal women.

Authors:  Elisabeth A Erekson; Sallis O Yip; Terri S Wedderburn; Deanna K Martin; Fang-Yong Li; Jennifer N Choi; Kimberly S Kenton; Terri R Fried
Journal:  Menopause       Date:  2013-09       Impact factor: 2.953

10.  Improving the identification of genitourinary syndrome of menopause through the utilization of the Day-to-Day Impact of Vaginal Aging questionnaire.

Authors:  Jennie Mastroianni; Julie A Thompson; Jan L Shifren; Andrea L Zuckerman; Katherine Pereira
Journal:  Menopause       Date:  2020-11       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.